Literature DB >> 17229710

New way of regulating alternative splicing in retroviruses: the promoter makes a difference.

Jens Bohne1, Axel Schambach, Daniela Zychlinski.   

Abstract

Alternative splicing has been recognized as a major mechanism for creating proteomic diversity from a limited number of genes. However, not all determinants regulating this process have been characterized. Using subviral human immunodeficiency virus (HIV) env constructs we observed an enhanced splicing of the RNA when expression was under control of the cytomegalovirus (CMV) promoter instead of the HIV long terminal repeat (LTR). We extended these observations to LTR- or CMV-driven murine leukemia proviruses, suggesting that retroviral LTRs are adapted to inefficient alternative splicing at most sites in order to maintain balanced gene expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17229710      PMCID: PMC1866029          DOI: 10.1128/JVI.02105-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity.

Authors:  M Ott; M Schnölzer; J Garnica; W Fischle; S Emiliani; H R Rackwitz; E Verdin
Journal:  Curr Biol       Date:  1999 Dec 16-30       Impact factor: 10.834

2.  A genomic view of alternative splicing.

Authors:  Barmak Modrek; Christopher Lee
Journal:  Nat Genet       Date:  2002-01       Impact factor: 38.330

3.  SR proteins and hnRNP H regulate the splicing of the HIV-1 tev-specific exon 6D.

Authors:  Massimo Caputi; Alan M Zahler
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

4.  The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element.

Authors:  T O Tange; C K Damgaard; S Guth; J Valcárcel; J Kjems
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

Review 5.  Co-transcriptional splicing of pre-messenger RNAs: considerations for the mechanism of alternative splicing.

Authors:  A C Goldstrohm; A L Greenleaf; M A Garcia-Blanco
Journal:  Gene       Date:  2001-10-17       Impact factor: 3.688

6.  A slow RNA polymerase II affects alternative splicing in vivo.

Authors:  Manuel de la Mata; Claudio R Alonso; Sebastián Kadener; Juan P Fededa; Matías Blaustein; Federico Pelisch; Paula Cramer; David Bentley; Alberto R Kornblihtt
Journal:  Mol Cell       Date:  2003-08       Impact factor: 17.970

7.  Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors.

Authors:  A Schambach; D Mueller; M Galla; M M A Verstegen; G Wagemaker; R Loew; C Baum; J Bohne
Journal:  Gene Ther       Date:  2006-06-08       Impact factor: 5.250

8.  A Janus splicing regulatory element modulates HIV-1 tat and rev mRNA production by coordination of hnRNP A1 cooperative binding.

Authors:  Virginie Marchand; Agnès Méreau; Sandrine Jacquenet; Denise Thomas; Annie Mougin; Renata Gattoni; James Stévenin; Christiane Branlant
Journal:  J Mol Biol       Date:  2002-11-01       Impact factor: 5.469

9.  Human p32 protein relieves a post-transcriptional block to HIV replication in murine cells.

Authors:  Yong-Hui Zheng; Hai-Feng Yu; B Matija Peterlin
Journal:  Nat Cell Biol       Date:  2003-07       Impact factor: 28.824

10.  The proline-rich region of the ecotropic Moloney murine leukaemia virus envelope protein tolerates the insertion of the green fluorescent protein and allows the generation of replication-competent virus.

Authors:  Otto Erlwein; Christian J Buchholz; Barbara S Schnierle
Journal:  J Gen Virol       Date:  2003-02       Impact factor: 3.891

View more
  5 in total

1.  Immunogenicity of a lentiviral-based DNA vaccine driven by the 5'LTR of the naturally attenuated caprine arthritis encephalitis virus (CAEV) in mice and macaques.

Authors:  Géraldine Arrode-Brusés; Ramakrishna Hegde; Yuhuai Jin; Zhengian Liu; Opendra Narayan; Yahia Chebloune
Journal:  Vaccine       Date:  2012-03-02       Impact factor: 3.641

2.  Characterization of the contribution of spliced RNAs of hepatitis B virus to DNA synthesis in transfected cultures of Huh7 and HepG2 cells.

Authors:  Teresa M Abraham; Eric B Lewellyn; Kathleen M Haines; Daniel D Loeb
Journal:  Virology       Date:  2008-07-26       Impact factor: 3.616

3.  The influenza A virus spliced messenger RNA M mRNA3 is not required for viral replication in tissue culture.

Authors:  David Jackson; Robert A Lamb
Journal:  J Gen Virol       Date:  2008-12       Impact factor: 3.891

Review 4.  Cat and Mouse: HIV Transcription in Latency, Immune Evasion and Cure/Remission Strategies.

Authors:  Aurélie Delannoy; Mikaël Poirier; Brendan Bell
Journal:  Viruses       Date:  2019-03-18       Impact factor: 5.048

5.  Limited complementarity between U1 snRNA and a retroviral 5' splice site permits its attenuation via RNA secondary structure.

Authors:  Daniela Zychlinski; Steffen Erkelenz; Vanessa Melhorn; Christopher Baum; Heiner Schaal; Jens Bohne
Journal:  Nucleic Acids Res       Date:  2009-12       Impact factor: 16.971

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.